Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
66,775,493
-
Share change
-
-16,265,847
-
Total reported value
-
$9,041,282,740
-
Put/Call ratio
-
168%
-
Price per share
-
$135.40
-
Number of holders
-
653
-
Value change
-
-$2,201,621,705
-
Number of buys
-
315
-
Number of sells
-
234
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2021
As of 30 Jun 2021 SPDR SERIES TRUST - S&P BIOTECH (XBI) had 653 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 66,775,493 shares of stock of the company.
Largest 10 holders included TORONTO DOMINION BANK, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, JPMORGAN CHASE & CO, MORGAN STANLEY, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, and BARCLAYS PLC.
This table shows 654 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.